Dr. de Carvalho is an Assistant Professor at Harvard Medical School, an Associate Surgeon and Urologic Oncologist at Brigham and Women’s Hospital and Dana-Farber Cancer Institute. His research focuses on the integration of genomic and transcriptomic data with pre-clinical models to define molecular mechanisms of cancer progression and resistance to therapy. As a computational biologist and urologic oncology, he is focused on applying computational tools and algorithms to tackle questions oriented towards treatment of urologic conditions.